Trade with Eva: Analytics in action >>
Showing posts with label ENDP. Show all posts
Showing posts with label ENDP. Show all posts

Friday, October 9, 2020

This week's biggest % winners & losers: October 5 - 9, 20 (wk 41)

This week's biggest % gainers/losers The following are this week's top percentage gainers and losers, categorized by sectors (over $300 mln market cap and 100K average daily volume).

This week's top % gainers

  • Healthcare: MYOK (221.08 +58.36%), ACRS (4.61 +55.57%), ENDP (4.93 +44.15%), NTLA (26.45 +40.47%), KNSA (20.7 +37.09%), ABEO (1.42 +35.23%)
  • Materials: KRA (25.23 +32.72%)
  • Industrials: BE (22.96 +43.77%)
  • Consumer Discretionary: GPRO (6.14 +34.65%), GME (12.18 +29.71%)
  • Information Technology: JKS (62.38 +41.34%), DDD (6.77 +38.91%), AYX (153.3 +35.56%), DQ (195.43 +31.35%)
  • Financials: EV (60.44 +53.56%)
  • Energy: AR (3.65 +30.93%)
  • Consumer Staples: SPTN (21.65 +31.61%)

This week's top % losers

  • Healthcare: CYTK (15.34 -36.06%), CRBP (1.2 -33.33%), ICPT (37.02 -9.99%), EVH (11.31 -8.72%)
  • Materials: VEDL (5.95 -18.89%)
  • Consumer Discretionary: SONO (13.83 -10.81%), PENN (64.94 -10.74%), DPZ (391.73 -9.69%)
  • Financials: SQQQ (21.73 -11.7%)
  • Energy: BTU (1.99 -16.74%), ARCH (39.48 -11.86%)

Long trade : Endo International (ENDP) +45% (10/20)

  • 10/2; #4;  vol. 4.5M;  $3.35       +45% 



Tuesday, May 9, 2017

Endo International (ENDP) reported earnings on Tue 9 May 2017 (b/o)

** charts before earnings **


 




** charts after earnings **






DUBLIN (AP) _ Endo International PLC (ENDP) on Tuesday reported a loss of $173.8 million in its first quarter.
The Dublin-based company said it had a loss of 78 cents per share. Earnings, adjusted for one-time gains and costs, came to $1.23 per share.
The results surpassed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.12 per share.
The health care company posted revenue of $1.04 billion in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $1.03 billion.
Endo expects full-year earnings in the range of $3.45 to $3.75 per share, with revenue in the range of $3.45 billion to $3.6 billion.
Endo shares have dropped 34 percent since the beginning of the year. The stock has dropped 33 percent in the last 12 months.